Takumi Fukumoto
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 376 publications
Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab.
Journal: Anticancer research
Published: May 23, 2026
ASO Author Reflections: Avoiding Mobilization in Laparoscopic Surgery for Huge Hepatocellular Carcinoma in the Right Posterior Section.
Journal: Annals of surgical oncology
Published: May 05, 2026
Usefulness of the Lymphocyte-to-Monocyte Ratio in Predicting Prognosis in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.
Journal: Oncology
Published: April 19, 2026
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 07, 2026
Prognosis Using Modified Albumin-Bilirubin Grade in Resected Biliary Tract Cancer: A Multicenter Propensity Score-matched Analysis.
Journal: Cancer diagnosis & prognosis
Published: March 25, 2026
Prognostic impact of malnutrition based on the global leadership initiative on malnutrition criteria in older patients undergoing liver resection for hepatocellular carcinoma.
Journal: Surgery today
Published: February 26, 2026
The convenience of contrast-enhanced intraoperative ultrasonic cholangiography in liver resection: a study protocol for a randomized, prospective, off-label trial.
Journal: BMC surgery
Published: February 22, 2026
A novel bile leak test using contrast-enhanced intraoperative ultrasonic cholangiography in liver resection: a prospective single-arm trial.
Journal: Surgical endoscopy
Published: February 03, 2026
Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study.
Journal: Hepatology (Baltimore, Md.)
Published: January 27, 2026
99mTc GSA scintigraphy predicts post-hepatectomy liver failure in biliary tract cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: January 19, 2026
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.
Journal: Journal of gastroenterology and hepatology
Published: January 19, 2026
Last Updated: 09/26/2026